IRCT2013071914054N1已完成2 期
The effectiveness of endocrine disorders therapy in depression improvement of HIV infected men referring to counseling center at Imam Khomeini hospital in 92
vice chancellor for research of Tehran University of Medical Sciences0 个研究点目标入组 104 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 104
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- Male
入选标准
- •HIV+ confirmed by Western Blot; Patient on ART treatment; beck questionnaire with score>21
- •Exclusion criteria: Consumption of antidepressant drugs; Confirmed endocrine disorder ; Any sign of infectious disease such as fever; Opportunistic infections; addiction; Major depression with suicidal attempt or emotional events in last month.
排除标准
- 未提供
研究者
相似试验
招募中
不适用
ocal treatment in addition to endocrine therapy in ER-positive/HER2-negative oligo-metastatic breast cancerKCT0003767Yonsei University Health System, Gangnam Severance Hospital110
尚未招募
不适用
Treatment of Endocrine disorders other than Diabetes Mellitus.CTRI/2021/06/034088Maria J Kamal
招募中
1 期
ExclUsive endocRine therapy Or radiation theraPy for women aged =70 years with luminal A-like early stage breast cancer (EUROPA): a randomized phase 3 trialMedDRA version: 20.0Level: PTClassification code: 10006187Term: Breast cancer Class: 100000004864breast cancerCTIS2023-508094-88-00niversity Of Florence926
已完成
2 期
Phase II Trial of Endocrine therapy for patients with Metastatic extramammary Paget's disease ExpRessing Androgen-Receptor using Darolutamide with/without LH-RH agonist.JPRN-jRCT2031220508akamura Yoshio40
进行中（未招募）
不适用
The CORE Study (Chemotherapy or Endocrine Treatment first?) - COREEUCTR2005-000986-20-DETechnical University of Munich1,500